Clinical Trials Logo

Clinical Trial Summary

This is a randomized study to compare the safety and efficacy of a single dose of up to 2 grams of cefazolin administered using a new drug delivery method called Ultrasonic Drug Delivery (UDD), combined with standard of care (SOC) antibiotic therapy, oral or IV, compared to standard of care (SOC) antibiotic therapy alone, in treating chronic wounds with skin and soft tissue infection, containing gram-positive pathogens, in lower extremities.


Clinical Trial Description

This is a Phase 2, single-center, parallel-group study to compare the efficacy and safety of UDD plus standard of care (SOC) with SOC alone for the treatment of skin and soft tissue infections in non-healing wounds. After review of screening results to determine eligibility, a patient will be randomly assigned to one of the two treatments:

Investigational Group: This group will receive administration of a single dose of cefazolin, using a novel new drug delivery system called Ultrasonic Drug Delivery (UDD), to the site of infection, combined with SOC, followed by best available adjunct therapy. An optional two additional treatments will be available if needed.

Comparator Group: This group will receive conventional standard of care treatment followed by best available adjunct therapy.

Efficacy will be assessed by clinical response based on the presence of vascularized granulation tissue, reduction of pain, temperature, measurement of lesion size and temperature, culture and gram stain results, and clinical signs of infection (erythema, induration/swelling, fluctuance, purulent drainage, warmth/localized heat, and tenderness/pain). Additionally, efficacy will be assessed by resolution of infection and microbiological assessments.

Safety will be assessed by reported adverse events, clinical laboratory tests (hematology, serum chemistry, fasting glucose, hs-CRP), and concomitant medication. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03732365
Study type Interventional
Source Sonescence, Inc.
Contact David G Armstrong, Ph.D., DPM
Phone (213) 740-2311
Email armstrong@usa.net
Status Not yet recruiting
Phase Phase 2
Start date February 1, 2019
Completion date July 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT03632031 - Treatment of Wounds Using Oasis® ECM
Completed NCT03230175 - Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) Phase 2
Completed NCT04483934 - Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts Phase 1/Phase 2
Terminated NCT04134143 - Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers Phase 1
Recruiting NCT04450693 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) Phase 3
Completed NCT06442865 - AMNIODERM+ Medical Device Clinical Study
Not yet recruiting NCT06327113 - Antibiotic Tumescent For Chronic Wounds Phase 2
Not yet recruiting NCT03049670 - The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study N/A
Not yet recruiting NCT05766982 - Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP) N/A
Completed NCT05921292 - Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies Early Phase 1
Completed NCT04176120 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU) Phase 3
Completed NCT02657876 - ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers Phase 1
Not yet recruiting NCT06109844 - FORCEREPAIR - A Wound Exudate Investigation
Terminated NCT04240574 - Debritom - Micro Water Jet Technology and Wound Healing N/A
Completed NCT05154838 - Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
Not yet recruiting NCT05251480 - Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People N/A
Completed NCT04344483 - Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh N/A
Recruiting NCT05739149 - A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers N/A
Completed NCT03863054 - An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
Recruiting NCT06028386 - Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers N/A